Your session is about to expire
← Back to Search
Communication Tool Training for Kidney Failure
N/A
Waitlist Available
Led By Amar Bansal, MD
Research Sponsored by University of Wisconsin, Madison
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from enrollment for up to 2 years
Awards & highlights
Study Summary
This trial will test whether the "Best Case/Worse Case" communication tool can help patients with end-stage renal disease receive appropriate palliative care and improve communication between patients and their caregivers.
Who is the study for?
This trial is for older adults with severe kidney disease (eGFR ≤ 24) who are not on dialysis but may have had it before or have the access in place. They must be over 80, have other serious illnesses, or their doctor wouldn't be surprised if they passed away within a year. Participants should speak English and be able to make decisions.Check my eligibility
What is being tested?
The study tests a 'Best Case/Worst Case' communication tool training for doctors at nephrology clinics. It aims to see if this improves end-of-life care quality and decision-making for patients with end-stage renal disease by comparing trained doctors to those waiting for training.See study design
What are the potential side effects?
Since this trial involves communication training rather than medical treatment, there are no direct physical side effects expected from participating in the study.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ from enrollment for up to 2 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from enrollment for up to 2 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Receipt of palliative care consult within 12 months of study enrollment, as determined by chart review or report by patient or caregiver
Secondary outcome measures
Caregiver-reported general quality of communication (QOC) received from study nephrologist
Caregiver-reported health related quality of life
Caregiver-reported quality of dying and death
+13 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Best Case/Worst Case communication toolExperimental Treatment1 Intervention
The participant's enrolled nephrologist will have completed training on the Best Case/Worst Case communication tool and will be encouraged to use it with the participant.
Group II: Usual CareActive Control1 Intervention
Usual care conversations are typically focused on mode and timing of dialysis, management of electrolytes and scheduling of laboratory testing. Conservative management or a treatment option of "no dialysis" is rarely mentioned.
Find a Location
Who is running the clinical trial?
Medical College of WisconsinOTHER
609 Previous Clinical Trials
1,162,176 Total Patients Enrolled
West Virginia UniversityOTHER
175 Previous Clinical Trials
55,899 Total Patients Enrolled
Icahn School of Medicine at Mount SinaiOTHER
858 Previous Clinical Trials
523,879 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am currently receiving dialysis.Your kidney function, as measured by eGFR, is very low.I am over 80, have a serious health condition, or my doctor wouldn't be surprised if I passed away within a year.I do not speak English.I am not currently undergoing dialysis.I am unable to make my own medical decisions.
Research Study Groups:
This trial has the following groups:- Group 1: Usual Care
- Group 2: Best Case/Worst Case communication tool
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
In what geographical areas is this trial currently being administered?
"The Medical College of Wisconsin in Milwaukee, West virginia University in Morgantown and the University of Pittsburgh in Pittsburgh are just a few places where this clinical trial is being conducted. Additional sites exist across 11 other locations."
Answered by AI
Is there an opportunity for participants to join this research initiative?
"The clinicaltrials.gov page for this medical experiment confirms that recruitment has ceased, as the last update was September 29th 2022 from when it opened on January 1st 2021. Despite this being inactive, 846 other trials are currently recruiting patients."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger